FLUIDIL Drug Patent Profile
✉ Email this page to a colleague
When do Fluidil patents expire, and when can generic versions of Fluidil launch?
Fluidil is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in FLUIDIL is cyclothiazide. Additional details are available on the cyclothiazide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLUIDIL?
- What are the global sales for FLUIDIL?
- What is Average Wholesale Price for FLUIDIL?
Summary for FLUIDIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 57 |
| Patent Applications: | 1,226 |
| DailyMed Link: | FLUIDIL at DailyMed |
US Patents and Regulatory Information for FLUIDIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | FLUIDIL | cyclothiazide | TABLET;ORAL | 018173-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
